Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno DrugsDHA:TECHNODRUG -2.27%37 Interest Coverage is 1.66 as of Mar. 2026, which is 14% below its 10-year median of 1.94. GuruFocus rates DHA:TECHNODRUG with a GF Score™ of 37/100. The stock has 10 warning signs investors should review. Among 686 Drug Manufacturers companies, Techno Drugs ranks worse than 88.19% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Techno Drugs's
Operating Income
for the
three
months ended in Mar. 2026 was BDT137 Mil. Techno Drugs's Interest Expense for the
three
months ended in Mar. 2026 was BDT-83 Mil.
Techno Drugs's interest coverage for the quarter that ended in Mar. 2026 was 1.66.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Techno Drugs's Interest Coverage or its related term are showing as below:
DHA:TECHNODRUG'
s Interest Coverage Range Over the Past 10 Years
Min: 1.62 Med: 1.94 Max: 2.18
Current: 1.62
DHA:TECHNODRUG's Interest Coverage is ranked worse than 88.19% of 686
companies
in the Drug Manufacturers industry
Industry Median: 12.645
vs DHA:TECHNODRUG: 1.62
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Techno Drugs Interest Coverage Related Terms
Techno Drugs Interest Coverage Historical Data
* Premium members only.
The historical data trend for Techno Drugs's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
DHA:TECHNODRUG vs ZTS, UTHR, VTRS: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Techno Drugs's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Drugs Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Techno Drugs's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Techno Drugs's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Drugs (DHA:TECHNODRUG) has a Interest Coverage of 1.66 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Techno Drugs and its competitors. This is 14% below median its historical median of 1.94. Over the past decade, Techno Drugs' Interest Coverage has ranged from 1.62 to 2.18. According to the industry distribution chart, Techno Drugs ranks #605 out of 686 companies in the Drug Manufacturers industry, placing it in the top 88.2%.
Is Techno Drugs' Interest Coverage too high?
Techno Drugs' current Interest Coverage of 1.66 is 14% below median its 10-year median of 1.94. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 2.18. The Drug Manufacturers industry median Interest Coverage is 12.65. Techno Drugs' value of 1.66 is 86.9% below this industry median. Based on the distribution chart, Techno Drugs ranks #605 out of 686 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Techno Drugs has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Techno Drugs' Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Techno Drugs ranks #605 out of 686 companies for Interest Coverage. This places Techno Drugs in the lower half of its industry. The industry median Interest Coverage is 12.65. Techno Drugs' value of 1.66 is 86.9% below this benchmark. Historically, Techno Drugs' own Interest Coverage has ranged from 1.62 to 2.18 over the past decade. While the company's 10-year median is 1.94 vs. the industry median of 12.65, Techno Drugs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.65, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Drugs's current Interest Coverage of 1.66 is 86.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Techno Drugs and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Drugs's current Interest Coverage is 1.66, which is 14% below median its own 10-year median of 1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Drugs stock overvalued right now?
Techno Drugs (DHA:TECHNODRUG) has a current Interest Coverage of 1.66. The current Interest Coverage is 1.66, which is 14% below median its 10-year median of 1.94 and 86.9% below the Drug Manufacturers industry median of 12.65. Techno Drugs' overall GF Score™ is 37/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Techno Drugs (DHA:TECHNODRUG), the current Interest Coverage is 1.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Techno Drugs Ltd is a pharmaceutical company. The company manufactures medicines for the healthcare market with quality products, a distribution channel, and doctor-patient acceptance. The company is also engaged in production of Anti-Cancer medicines and medicines for therapeutic areas like oncology, cardiovascular, diabetes, immune suppressor, anesthetics, life-saving antibiotics & contrast media in Bangladesh. The product portfolio of the company include Algicar Plus, Amoclav Forte, Adesol Oral Solution, Aminovet Injection, Apegestrol Tab, Docetex 20 Inj, and others.
37GF Score
Get the complete analysis for DHA:TECHNODRUG
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:TECHNODRUG has been successfully added to your 
